"Ritanserin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
| Descriptor ID |
D016713
|
| MeSH Number(s) |
D03.383.621.840 D03.383.742.698.700
|
| Concept/Terms |
Ritanserin- Ritanserin
- 6-(2-(4-(Bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-5H-thiazolo(3,2-a)pyrimidin-5-one
|
Below are MeSH descriptors whose meaning is more general than "Ritanserin".
Below are MeSH descriptors whose meaning is more specific than "Ritanserin".
This graph shows the total number of publications written about "Ritanserin" by people in this website by year, and whether "Ritanserin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ritanserin" by people in Profiles.
-
Ritanserin, a novel agent targeting the mesenchymal subtype of glioblastomas. Neuro Oncol. 2018 01 22; 20(2):151-152.
-
Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha. Neuro Oncol. 2018 01 22; 20(2):192-202.
-
Ritanserin in the treatment of cocaine dependence. Biol Psychiatry. 1997 Nov 15; 42(10):932-40.